Human proteins

ืžื›ื™ืœ ืžื•ื“ืขื•ืชืจื›ื™ืฉื•ืช ืžืชื•ืš ื”ืืคืœื™ืงืฆื™ื”
130 ื‘ื™ืงื•ืจื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ืœื›ื•ืœื ืžื’ื™ืœ 10 ื•ืžืขืœื”
+10Kโ€
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ืœื›ื•ืœื ืžื’ื™ืœ 10 ื•ืžืขืœื”
ืจื›ื™ืฉื•ืช ื‘ืชื•ืš ื”ืืคืœื™ืงืฆื™ื”
ืœืžื™ื“ืข ื ื•ืกืฃ
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื”ื–ื•

ื—ืœื‘ื•ื ื™ื ืื ื•ืฉื™ื™ื

ื”ื™ื™ืฉื•ื ื”ื—ื™ื ืžื™ "ื—ืœื‘ื•ื ื™ื ืื ื•ืฉื™ื™ื" ื”ื•ื ื™ื“ื™ื“ื•ืชื™ ืžืื•ื“, ื™ืฉ ืœื• ืžืžืฉืง ื™ืคื” ื•ืคืฉื•ื˜. ื”ื‘ื—ื™ืจื” ื”ื˜ื•ื‘ื” ื‘ื™ื•ืชืจ ืœืžื™ืœื•ืŸ ื›ื™ืก ืฉื ืžืฆื ืชืžื™ื“ ื‘ื”ื™ืฉื’ ื™ื“. ืžื”ื ื ื™ืชืŸ ืœืœืžื•ื“ ื”ืจื‘ื” ื“ื‘ืจื™ื ื—ื“ืฉื™ื ื•ืžืขื ื™ื™ื ื™ื, ืœืžืฉืœ:

ื—ืœื‘ื•ืŸ X ื”ืžืฉื•ื™ืš Bcl-2
ืจื’ื•ืœื˜ื•ืจ ืืคื•ืคื˜ื•ื–ื™ืก BAX, ื”ืžื›ื•ื ื” ื’ื ื—ืœื‘ื•ืŸ 4 ื“ืžื•ื™ bcl-2, ื”ื•ื ื—ืœื‘ื•ืŸ ืฉื‘ืื“ื ืžืงื•ื“ื“ ืขืœ ื™ื“ื™ ื”ื’ืŸ BAX. BAX ื”ื•ื ื‘ืŸ ืœืžืฉืคื—ืช ื”ื’ื ื™ื Bcl-2. ื‘ื ื™ ืžืฉืคื—ืช BCL2 ื™ื•ืฆืจื™ื ื”ื˜ืจื•-ืื• ื”ื•ืžื•ื“ื™ืžืจื™ื ื•ืคื•ืขืœื™ื ื›ื•ื•ื™ืกื•ืช ืื ื˜ื™ ืื• ืคืจื•-ืืคื•ืคื˜ื•ื˜ื™ื•ืช ื”ืžืขื•ืจื‘ื™ื ื‘ืžื’ื•ื•ืŸ ืจื—ื‘ ืฉืœ ืคืขื™ืœื•ื™ื•ืช ืกืœื•ืœืจื™ื•ืช. ื—ืœื‘ื•ืŸ ื–ื” ื™ื•ืฆืจ ื”ื˜ืจื•ื“ื™ืžืจ ืขื BCL2, ื•ืžืชืคืงื“ ื›ืžืคืขื™ืœ ืืคื•ืคื˜ื•ื˜ื™. ื—ืœื‘ื•ืŸ ื–ื” ืžื“ื•ื•ื— ื›ื™ ื”ื•ื ืžืงื™ื™ื ืื™ื ื˜ืจืืงืฆื™ื” ืขื, ื•ืžื’ื‘ื™ืจ ืืช ืคืชื™ื—ืชื• ืฉืœ ืชืขืœืช ื”ืื ื™ื•ืŸ ื”ืžื™ืชื•ื›ืชืจื™ืช ื”ืžืชื—ื™ืช ื”ืžื™ืชื•ื›ื•ื ื“ืจื™ืช (VDAC), ืžื” ืฉืžื•ื‘ื™ืœ ืœืื•ื‘ื“ืŸ ืคื•ื˜ื ืฆื™ืืœ ื”ืžืžื‘ืจื ื” ื•ืฉื—ืจื•ืจ ืฆื™ื˜ื•ื›ืจื•ื C. ื”ื‘ื™ื˜ื•ื™ ืฉืœ ื’ืŸ ื–ื” ืžื•ื•ืกืช ืขืœ ื™ื“ื™ ืžื“ื›ื ื”ื’ื™ื“ื•ืœื™ื P53 ื•ื”ื•ื›ื— ืฉื”ื•ื ืžืขื•ืจื‘ ื‘ืืคื•ืคื˜ื•ื–ื™ืก ื‘ืชื™ื•ื•ืš P53.

ืคืคื˜ื™ื“ C-
ื”ืคืคื˜ื™ื“ ื”ืžืงืฉืจ, ืื• C-peptide, ื”ื•ื ืคื•ืœื™ืคืคื˜ื™ื“ ืงืฆืจ-31-ืืžื™ื ื•-ื—ื•ืžืฆื” ื”ืžื—ื‘ืจ ืืช ืฉืจืฉืจืช ื”- A ืฉืœ ืื™ื ืกื•ืœื™ืŸ ืœืฉืจืฉืจืช ื”- B ืฉืœื• ื‘ืžื•ืœืงื•ืœืช ื”ืคืจื•ืื™ื ืกื•ืœื™ืŸ. ื‘ื”ืงืฉืจ ืฉืœ ืกื•ื›ืจืช ืื• ื”ื™ืคื•ื’ืœื™ืงืžื™ื”, ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ืžื“ื™ื“ื” ืฉืœ ืจืžื•ืช ืกืจื•ื ื”ื“ื C-peptide ื›ื“ื™ ืœื”ื‘ื“ื™ืœ ื‘ื™ืŸ ืžืฆื‘ื™ื ืฉื•ื ื™ื ืขื ืชื›ื•ื ื•ืช ืงืœื™ื ื™ื•ืช ื“ื•ืžื•ืช.

ACOX1
Perylisomal Acyl-Coenzyme ืื•ืงืกื™ื“ืื– 1 ื”ื•ื ืื ื–ื™ื ืฉื‘ื‘ื ื™ ืื“ื ืžืงื•ื“ื“ ืขืœ ื™ื“ื™ ื”ื’ืŸ ACOX1.

ืชื›ื•ื ื•ืช :
โ€ข ื”ืžื™ืœื•ืŸ ืคื•ืขืœ ื‘ืžืฆื‘ ืœื ืžืงื•ื•ืŸ - ืื™ื ื›ื ื–ืงื•ืงื™ื ืœื—ื™ื‘ื•ืจ ืื™ื ื˜ืจื ื˜. ื’ื™ืฉื” ืœืžืืžืจื™ื (ืชื™ืื•ืจื™ื) ื‘ืžืฆื‘ ืœื ืžืงื•ื•ืŸ, ืœืœื ื—ื™ื‘ื•ืจ ืœืื™ื ื˜ืจื ื˜ (ืœืžืขื˜ ืชืžื•ื ื•ืช);
โ€ข ื—ื™ืคื•ืฉ ืžื”ื™ืจ ืžืื•ื“ ืื—ืจ ืชื™ืื•ืจื™ื. ืžืฆื•ื™ื“ ื‘ืคื•ื ืงืฆื™ื™ืช ื—ื™ืคื•ืฉ ื“ื™ื ืืžื™ืช ืžื”ื™ืจื” - ื”ืžื™ืœื•ืŸ ื™ืชื—ื™ืœ ืœื—ืคืฉ ืžื™ืœื™ื ื‘ืžื”ืœืš ื”ืงืœื˜;
โ€ข ืžืกืคืจ ื‘ืœืชื™ ืžื•ื’ื‘ืœ ืฉืœ ื”ืขืจื•ืช (ืžื•ืขื“ืคื™ื);
โ€ข ืกื™ืžื ื™ื” - ืืชื” ื™ื›ื•ืœ ืœื”ื•ืกื™ืฃ ืชื™ืื•ืจื™ื ืœืจืฉื™ืžืช ื”ืžื•ืขื“ืคื™ื ืฉืœืš ืขืœ ื™ื“ื™ ืœื—ื™ืฆื” ืขืœ ืกืžืœ ื”ื›ื•ื›ื‘ื™ืช;
โ€ข ื ื™ื”ื•ืœ ืจืฉื™ืžื•ืช ืกื™ืžื ื™ื•ืช - ื‘ืืคืฉืจื•ืชืš ืœืขืจื•ืš ืืช ืจืฉื™ืžื•ืช ื”ืกื™ืžื ื™ื•ืช ืฉืœืš ืื• ืœื ืงื•ืช ืื•ืชืŸ;
โ€ข ื—ืคืฉ ื”ื™ืกื˜ื•ืจื™ื”;
โ€ข ื—ื™ืคื•ืฉ ืงื•ืœื™;
โ€ข ืชื•ืื ืœื’ืจืกืื•ืช ืžื•ื“ืจื ื™ื•ืช ืฉืœ ืžื›ืฉื™ืจื™ ืื ื“ืจื•ืื™ื“;
โ€ข ื‘ื™ืฆื•ืขื™ื ื™ืขื™ืœื™ื ืžืื•ื“, ืžื”ื™ืจื™ื ื•ื˜ื•ื‘ื™ื;
โ€ข ื“ืจืš ืงืœื” ืœืฉืชืฃ ืขื ื—ื‘ืจื™ื;
โ€ข ื”ื™ื™ืฉื•ื ืงืœ ืžืื•ื“ ืœืฉื™ืžื•ืฉ, ืžื”ื™ืจ ื•ื‘ืชื•ื›ืŸ ื ืจื—ื‘;
โ€ข ืขื“ื›ื•ื ื™ื ืื•ื˜ื•ืžื˜ื™ื™ื ื‘ื—ื™ื ื ื‘ื›ืœ ืคืขื ืฉื ื•ืกืคื™ื ืชื ืื™ื ื—ื“ืฉื™ื;
โ€ข ื”ืกืคืจื™ื™ื” "ื—ืœื‘ื•ื ื™ื ืื ื•ืฉื™ื™ื" ืžื™ื•ืขื“ืช ืœืชืคื•ืก ื›ืžื” ืฉืคื—ื•ืช ื–ื™ื›ืจื•ืŸ.

ืชื›ื•ื ื•ืช ืคืจื™ืžื™ื•ื :
โœ“ ืื™ืŸ ืžื•ื“ืขื•ืช ;
โœ“ ืชืžื•ื ื•ืช, ืชืžื•ื ื•ืช ื’ื™ืฉื” ื‘ืžืฆื‘ ืœื ืžืงื•ื•ืŸ ;
โœ“ ื ืงื” ืืช ื”ื™ืกื˜ื•ืจื™ื™ืช ื”ื’ืœื™ืฉื” .
ื›ืœ ืžื” ืฉืืชื” ืจื•ืฆื” ืœื“ืขืช ืขืœ ื—ืœื‘ื•ื ื™ื ืื ื•ืฉื™ื™ื!
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
21 ื‘ืกืคื˜ืณ 2026
ืกื™ืคื•ืจื™ื ืžื•ืžืœืฆื™ื

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.
  • ืœื ืžืชื‘ืฆืข ืฉื™ืชื•ืฃ ื ืชื•ื ื™ื ืขื ืฆื“ื“ื™ื ืฉืœื™ืฉื™ื™ื
  • ื”ืืคืœื™ืงืฆื™ื” ื”ื–ืืช ืขืฉื•ื™ื” ืœืืกื•ืฃ ืืช ืกื•ื’ื™ ื”ื ืชื•ื ื™ื ื”ืืœื”
    ืคืขื™ืœื•ืช ื‘ืืคืœื™ืงืฆื™ื•ืช, ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื•ื‘ื™ืฆื•ืขื™ ื”ืืคืœื™ืงืฆื™ื” ื•ืžื–ื”ื” ื”ืžื›ืฉื™ืจ ืื• ืžื–ื”ื™ื ืื—ืจื™ื
  • ื”ื ืชื•ื ื™ื ืžื•ืฆืคื ื™ื ื‘ื–ืžืŸ ื”ื”ืขื‘ืจื”
  • ืื™ ืืคืฉืจ ืœืžื—ื•ืง ืืช ื”ื ืชื•ื ื™ื

ื“ื™ืจื•ื’ื™ื ื•ื‘ื™ืงื•ืจื•ืช

120 ื‘ื™ืงื•ืจื•ืช

ืžื” ื—ื“ืฉ?

A major update for your Human Proteins guide! Fresh design, smarter search and a wealth of new content.
- Easier PDF reports;
- New color themes;
- Optimized for tablets;
- Full-text search;
- Bug fixes + new articles.
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ืœื›ื•ืœื ืžื’ื™ืœ 10 ื•ืžืขืœื”
ืจื›ื™ืฉื•ืช ื‘ืชื•ืš ื”ืืคืœื™ืงืฆื™ื”
ืœืžื™ื“ืข ื ื•ืกืฃ

ืชืžื™ื›ื” ื‘ืืคืœื™ืงืฆื™ื”

ืžื™ื“ืข ืขืœ ืžืคืชื—ื™ ื”ืืคืœื™ืงืฆื™ื”
Anna Voronich
softanna@outlook.com
Avenida da Liberdade , Bloco S - 1ยบC 2430-229 Marinha Grande Portugal

โ€ซืขื•ื“ ืžื‘ื™ืช Anna Voronichโ€Žโ€